Review of utilization of trastuzumab in the adjuvant treatment of breast cancer in four university-teaching hospitals in Quebec, Canada
Nathalie Letarte(Centre Hospitalier de l’Université de Montréal), Radhika Rajan(Centre Hospitalier Universitaire Sainte-Justine), Maurice Stephan Michel(Heidelberg University), Brittney E. Bailey(Centre Hospitalier Universitaire Sainte-Justine), Hemant K. Roy(Mymensingh Medical College Hospital), L Deschênes(Centre Hospitalier Universitaire Sainte-Justine), Benoît Cossette(Université de Sherbrooke), Dominic Pilon(Group for Research in Decision Analysis), Claire Dupont(Centre Hospitalier Universitaire Sainte-Justine), Daniel Froment(Centre Hospitalier Universitaire Sainte-Justine)
Cited by 1
Related Papers
Cohort Profile: The Canadian Longitudinal Study on Aging (CLSA)
|International Journal of Epidemiology|2019|528
AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis
|Carcinogenesis|2002|347
Percutaneous nephrolithotomy with ultrasonography‐guided renal access: experience from over 300 cases
|British Journal of Urology|2005|279